Initial experience of radiofrequency ablation for the treatment of advanced haemorrhoidal disease.
Haemorrhoidal Severity Score
Rafaelo®
haemorrhoids
radiofrequency ablation
Journal
Przeglad gastroenterologiczny
ISSN: 1895-5770
Titre abrégé: Prz Gastroenterol
Pays: Poland
ID NLM: 101280380
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
06
2021
accepted:
06
07
2021
entrez:
21
9
2022
pubmed:
22
9
2022
medline:
22
9
2022
Statut:
ppublish
Résumé
The ideal approach to the management of haemorrhoidal disease (HD) remains to be elucidated. A procedure that returns the anal cushions to their normal size without destroying them or damaging the surrounding tissues is sought. Radiofrequency ablation (RFA) overcomes many of the disadvantages of the previously described repairs and may be a valuable alternative in the management of advanced HD. To evaluate the efficacy and outcomes of the Rafaelo A retrospective observational study was carried out between June 2019 and October 2020. The haemorrhoidal severity score (HSS), the Cleveland Incontinence Score (CIS), and the visual analogue scale (VAS) for pain were compared prior to and post procedure using a paired t-test. Forty-seven patients were included in the study, with a mean age of 43 years. All individual symptom scores of HSS showed statistically significant improvement post RFA ( The RFA technique is a safe and effective treatment alternative for advanced HD. It results in a statistically significant improvement in the symptoms of HD and is associated with minimal discomfort to the patient with early return to normal activity.
Identifiants
pubmed: 36127948
doi: 10.5114/pg.2021.110011
pii: 45436
pmc: PMC9475478
doi:
Types de publication
Journal Article
Langues
eng
Pagination
234-239Informations de copyright
Copyright © 2022 Termedia.
Déclaration de conflit d'intérêts
The Rafaelo® equipment was provided to our hospital free of cost by F Care Systems, Antwerp, Belgium. However, the authors had full control of the primary data and study design. The authors declare no conflict of interest.
Références
MedGenMed. 2002 Jul 31;4(3):1
pubmed: 12466744
Dis Colon Rectum. 2011 Sep;54(9):1059-64
pubmed: 21825884
Anaesthesia. 2019 Mar;74(3):373-379
pubmed: 30648259
Dis Colon Rectum. 1976 Apr;19(3):213-8
pubmed: 1269347
Dis Colon Rectum. 1991 Jan;34(1):78-82
pubmed: 1991426
J Surg Res. 2005 Jun 1;126(1):66-72
pubmed: 15916977
N Engl J Med. 2014 Sep 4;371(10):944-51
pubmed: 25184866
World J Gastrointest Surg. 2016 Sep 27;8(9):614-620
pubmed: 27721924
Obstet Gynecol. 2001 Dec;98(6):1130-9
pubmed: 11755566
J Med Life. 2013 Sep 15;6(3):302-6
pubmed: 24146691
Int Surg. 2015 Jan;100(1):44-57
pubmed: 25594639
Tech Coloproctol. 2019 Jan;23(1):33-41
pubmed: 30725242
Lancet. 2016 Jul 23;388(10042):356-364
pubmed: 27236344
Gastrointest Endosc. 1997 Nov;46(5):435-43
pubmed: 9402118
Eur Rev Med Pharmacol Sci. 2012 Apr;16(4):548-53
pubmed: 22696885
Dis Colon Rectum. 1999 Mar;42(3):419-20
pubmed: 10223766
Dis Colon Rectum. 1993 Jan;36(1):77-97
pubmed: 8416784
Curr Surg. 2003 Jul-Aug;60(4):452-8
pubmed: 14972240
Tech Coloproctol. 2006 Oct;10(3):181-6
pubmed: 16969619
Dis Colon Rectum. 1999 Mar;42(3):421-3
pubmed: 10223767
Int J Colorectal Dis. 2009 Apr;24(4):455-60
pubmed: 18777127
Tech Coloproctol. 2019 Aug;23(8):769-774
pubmed: 31399891
Medicina (Kaunas). 2004;40(3):232-7
pubmed: 15064544
Ther Adv Chronic Dis. 2017 Oct;8(10):141-147
pubmed: 28989595
Int J Colorectal Dis. 2012 Feb;27(2):215-20
pubmed: 21932016